Package Leaflet: Information for the User
Atorvastatina Cinfa 60 mg Film-Coated Tablets
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Atorvastatina Cinfa belongs to a group of medicines known as statins, which are medicines that regulate lipids (fats).
Atorvastatina Cinfa is used to reduce lipids such as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes on their own have failed. If you present a high risk of heart disease, atorvastatina can also be used to reduce this risk even though your cholesterol levels are normal. During treatment, a standard low-cholesterol diet must be followed.
Do not take Atorvastatina Cinfa:
(listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting to take Atorvastatina Cinfa:
In any of these cases, your doctor may instruct you to have blood tests before and possibly during treatment with atorvastatin to predict the risk of experiencing muscle-related adverse effects. It is known that the risk of experiencing muscle-related adverse effects (e.g. rhabdomyolysis) increases when certain medicines are taken at the same time (see section 2 “Other medicines and Atorvastatina Cinfa”).
Also inform your doctor or pharmacist if you experience persistent muscle weakness. Further tests and additional medicines may be necessary to diagnose and treat this problem.
While taking this medicine, your doctor will monitor if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugars and fats in your blood, being overweight and high blood pressure.
Other medicines and Atorvastatina Cinfa
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine.
There are some medicines that may affect the proper functioning of atorvastatin or the effects of these medicines may be modified by atorvastatin. This type of interaction may reduce the effect of one or both medicines. Alternatively, this combined use may increase the risk or severity of adverse effects, including the important muscle deterioration, known as rhabdomyolysis described in section 4:
Atorvastatina Cinfa with food, drinks and alcohol
See section 3 for instructions on how to take atorvastatin. Please note the following:
Orange juice
Do not take more than one or two small glasses of orange juice per day because large amounts of orange juice may alter the effects of atorvastatin.
Alcohol
Avoid drinking large amounts of alcohol while taking this medicine. See details in section 2 “Warnings and precautions”.
Pregnancy, breastfeeding and fertility
Do not take atorvastatin if you are pregnant, think you may be pregnant or are trying to become pregnant.
Do not take atorvastatin if you are fertile and do not use adequate contraceptive measures. Do not take atorvastatin if you are breastfeeding your child.
Atorvastatin has not been shown to be safe during pregnancy and breastfeeding.
Consult your doctor or pharmacist before using any medicine.
Driving and operating machinery
Normally this medicine does not affect your ability to drive or operate machinery. However, do not drive if this medicine affects your ability to drive. Do not operate tools or machinery if this medicine affects your ability to operate them.
Atorvastatina Cinfa contains lactose and sucrose.
If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medicine.
Atorvastatina Cinfa contains sodium.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Before starting treatment, your doctor will put you on a low-cholesterol diet, which you must also follow during treatment with atorvastatina.
The recommended initial dose of atorvastatina is 10 mg once a day in adults and children aged 10 years and above. Your doctor may increase it if necessary to reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more. The maximum dose of atorvastatina is 80 mg once a day.
Atorvastatina tablets should be swallowed whole with a glass of water and can be taken at any time of the day with or without food. However, try to take your tablet every day at the same time.
Your doctor will decide the duration of treatment with Atorvastatina Cinfa
Ask your doctor if you think the effect of atorvastatina is too strong or too weak.
If you take more Atorvastatina Cinfa than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
Take the remaining tablets, the packaging, and the complete box with you so that hospital staff can easily identify the medication you have taken.
If you forget to take Atorvastatina Cinfa
If you forget to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to make up for the missed doses.
If you interrupt treatment with Atorvastatina Cinfa
If you have any other questions about the use of this medication or want to interrupt treatment, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you notice any of the following side effects or severe symptoms, stop taking these tablets and inform your doctor immediately or visit the nearest hospital emergency service.
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Other possible side effects with Atorvastatina Cinfa
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Frequency not known: cannot be estimated from available data:
Consult your doctor if you experience weakness in the arms or legs that worsens after periods of activity, double vision or eyelid drooping, difficulty swallowing or difficulty breathing.
The possible side effects of some statins (medicines of the same type):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
This medication does not require special conditions for conservation.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Atorvastatina Cinfa
Tablet core:Lactose monohydrate, Laurilsulfate of sodium, Butilhydroxyanisol (E-320), Crospovidone, Magnesium stearate, Microcrystalline cellulose (E-460), Anhydrous colloidal silica, Saccharose, Triester of sorbitan, Stearate of macrogol 40 (E-431), Dimethicone, Silica, 2, Bromo-2-Nitropropano-1,3-diol, Sodium bicarbonate.
Coating: Lactose monohydrate, Hypromelose (E-464), Titanium dioxide (E-171), Macrogol 4000.
Appearance of the product and contents of the packaging
The tablets are coated with a film, white, oblong, biconvex, and marked with the code “AT6”.
The packaging contains 28 tablets.
Holder of the marketing authorization and responsible manufacturer
Cinfa Laboratories, S.A.
Carretera Olaz-Chipi, 10. Industrial Park Areta
31620 Huarte (Navarra) - Spain
Last review date of this leaflet:October 2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
You can access detailed and updated information on this medication by scanning with your mobile phone (smartphone) the QR code included in the leaflet and packaging. You can also access this information at the following internet address:https://cima.aemps.es/cima/dochtml/p/85716/P_85716.html
QR code to:https://cima.aemps.es/cima/dochtml/p/85716/P_85716.html
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.